- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03776188
Endoscopic Suturing (ES) Registry
Prospective Registry for Trans-Orifice Endoscopic Suturing Applications
To determine patient outcomes (survival, additional endoscopic or surgical procedures) with an endoscopic suturing technique at predetermined intervals compared to historical controls when applicable.
To evaluate the efficacy, safety, and durability of trans-orifice endoscopic suturing therapy for revision of bariatric procedures as well as study the safety, efficacy, and durability of preventative fixation of GI endoprosthetics.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
To determine patient outcomes (survival, morbidity including hospitalization, additional re-interventions with radiologic, endoscopic or surgical procedures) with endoscopic suturing at predetermined intervals from the last endoscopic suturing procedure or at failure of the endoscopic suturing with conversion to another intervention such as surgery and compared to historical controls when applicable.
To evaluate the efficacy and safety of endoscopic suturing therapy in preventative fixation of stents and bariatric revision.
To collect data on the common use endoscopic suturing therapy in other indications.
This prospective clinical study is a real-world registry and not a randomized controlled trial. Given the conditions commonly treated with endoscopic suturing and the potential lack of equivalent expertise in open, laparoscopic, and trans-oral surgical procedures at all centers, randomization of participants is not possible nor ethical. In addition, there are clinical scenarios where endoscopic therapy with surgical sutures, tissue sealants, and/or endoprosthetics may be appropriate and open and laparoscopic surgical approaches inappropriate from an ethical viewpoint. Given the multitude of currently available minimally invasive approaches to repair, it would be unethical to expose and randomize patients who are suitable for more minimally invasive approaches to a more invasive and inherently more morbid approach.
This outcomes study is external to the subject receiving the medical device treatment. Subjects will receive the medical device treatment regardless of study participation and the surgery is not part of this research. Subjects will be consented prior to their procedure, to obtain basic follow-up information. If the subject provides informed consent to participate in the registry, then site staff will follow the participant's clinical data for the period of the registry. Site staff may also contact the subject(s) during their standard clinic visit or via the telephone and obtain information on: overall health, specific events related to any subsequent surgical, endoscopic, or radiologic interventions, and hospitalizations.
The clinical data will be collected during usual procedure follow-ups. This will include recording patient demographics, medications, testing results, comorbidities, body mass index, and reason for clinical care visit. If during the follow-up period, the subject undergoes additional clinically indicated procedures or hospitalizations for procedure related indications then the site will submit this information to the registry.
All procedures and device use will be performed as clinically indicated and as directed by the treating physician. All information requested as part of this registry will be obtained from clinical data obtained as part of study.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Arkansas
-
Little Rock, Arkansas, États-Unis, 72211
- University of Arkansas
-
-
Florida
-
Jacksonville, Florida, États-Unis, 32224
- Mayo Clinic Jacksonville
-
Jacksonville, Florida, États-Unis, 32256
- Borland Grover Clinic
-
-
Illinois
-
Evanston, Illinois, États-Unis, 60201
- NorthShore University HealthSystem
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21224
- Johns Hopkins Medical Institution
-
-
Missouri
-
Saint Louis, Missouri, États-Unis, 63110
- Washington University
-
-
New York
-
Manhasset, New York, États-Unis, 11030
- Northwell Health
-
New York, New York, États-Unis, 10021
- New York Presbyterian Hospital
-
New York, New York, États-Unis, 10029
- Mount Sinai Hospital
-
-
Pennsylvania
-
Hershey, Pennsylvania, États-Unis, 17033
- Penn State Hershey Medical Center
-
-
Texas
-
Dallas, Texas, États-Unis, 75214
- Methodist Dallas Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Selected to undergo trans-orifice suturing prior to study enrollment
- Age 18+ years
- Patient ASA classification I, II, III, including emergency cases
- Patient willing to provide informed consent, cooperate with post-operative recommendations and follow-up assessment
Exclusion Criteria:
- Patients who do not meet the clinical criteria for trans-orifice suturing
- Under age 18 years
- ASA classification IV
- Unable to provide informed consent
- Unable to participate in follow-up assessments
- Uncorrectable coagulopathy at the time of endoscopic suturing
- Any terminal disease that limits patient's survival to less than one year
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
---|
no groups - observational study
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Dislocation of Stent - distance
Délai: Change at 2 weeks, 30 days, 3 months
|
Change in the position measured using distance (centimeters).
|
Change at 2 weeks, 30 days, 3 months
|
Dislocation of Stent - location
Délai: Change at 2 weeks, 30 days, 3 months
|
Change in the position measured using location.
Location options: Bridging the GJ anastomosis, Confined to gastric lumen, Bridging the pylorus, Bridging Lower Esophageal Sphincter
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - placement
Délai: Change at 2 weeks, 30 days, 3 months
|
Distal from placement over time (yes or no)
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - replaced
Délai: Change at 2 weeks, 30 days, 3 months
|
Stent replaced or re-structured over time (yes or no)
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - sutures
Délai: Change at 2 weeks, 30 days, 3 months
|
Number of intact Sutures
|
Change at 2 weeks, 30 days, 3 months
|
Migration Rate of Stent - removal
Délai: Change at 2 weeks, 30 days, 3 months
|
Days to removal and replacement
|
Change at 2 weeks, 30 days, 3 months
|
Excess Weight Loss
Délai: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % excess weight lost and absolute terms.
|
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Total Weight Loss
Délai: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % total weight loss and absolute terms.
|
Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Jennifer Maranki, MD, Penn State Milton S. Hershey School of Medicine
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- ES Registry 2-682-101
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .